<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30251" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Tonsil Cancer</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Williamson</surname>
            <given-names>Andrew J.</given-names>
          </name>
          <aff>Imperial College London</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mullangi</surname>
            <given-names>Sanjana</given-names>
          </name>
          <aff>Hillcrest Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gajra</surname>
            <given-names>Ajeet</given-names>
          </name>
          <aff>SUNY Upstate Medical University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Andrew Williamson declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sanjana Mullangi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ajeet Gajra declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>4</day>
          <month>9</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30251.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Tonsil cancer is the most common form of oropharyngeal malignancy, and its incidence is sharply rising due to the increasing prevalence of human papillomavirus (HPV)-induced cancers. The presence of HPV can dramatically alter the prognosis of tonsillar cancer, and there have recently been significant changes made to the World Health Organization classification and TNM staging system to reflect this. Tonsil cancer can be managed by both surgical and oncologic approaches, although the optimal treatment regimen remains an area of ongoing research. This activity reviews the evaluation and management of tonsil cancer and highlights the role of interprofessional team members in collaborating to provide well-coordinated care and enhance outcomes for affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify when tonsil cancer should be considered on differential diagnosis.</p></list-item><list-item><p>Identify risk factors for tonsil cancer.</p></list-item><list-item><p>Outline management strategies for tonsil cancer.</p></list-item><list-item><p>Employ interprofessional team strategies for improving care coordination and communication to advance the management of tonsil cancer and improve patient outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30251&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30251">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30251.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Tonsil cancer is the most common form of&#x000a0;oropharyngeal malignancy, and its incidence is&#x000a0;sharply&#x000a0;rising due to the increasing prevalence of human papillomavirus (HPV)-induced cancers. The presence of HPV can dramatically alter the prognosis of tonsillar cancer, and there have recently been significant changes made to the WHO classification and TNM staging to reflect this. Tonsil cancer can be managed&#x000a0;by both surgical and oncological approaches, although the optimal treatment regimen remains an area of&#x000a0;ongoing research.</p>
      </sec>
      <sec id="article-30251.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Traditionally, oropharyngeal and tonsil cancers were&#x000a0;attributed to smoking and alcohol misuse, with the former remaining an independent&#x000a0;indicator of poor prognosis. In more recent years; however, there has been a sharp increase in the number of cases occurring secondary to HPV, with up to 93% of new oropharyngeal cancers in Western Europe&#x000a0;showing HPV positivity.<xref ref-type="bibr" rid="article-30251.r1">[1]</xref>&#x000a0;Additionally, there is a growing body of evidence to suggest having a spouse with HPV-related cancer can result in a slight increase in the likelihood of developing oropharyngeal and anogenital cancers.<xref ref-type="bibr" rid="article-30251.r2">[2]</xref></p>
      </sec>
      <sec id="article-30251.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Large epidemiological studies have shown&#x000a0;tonsils are the most common site of oropharyngeal cancer, compromising 23.1% of all malignancies in this anatomical region, with an overall incidence rate of 8.4 cases per 100,000.<xref ref-type="bibr" rid="article-30251.r3">[3]</xref>&#x000a0;Of concern, the rate of tonsil and oropharyngeal cancers has increased dramatically in the last 40 years.&#x000a0;This&#x000a0;significant&#x000a0;rise has&#x000a0;been attributed to the "viral epidemic" of HPV, with western countries&#x000a0;seeing an increase&#x000a0;in the proportion of HPV-associated&#x000a0;cancers from&#x000a0;42.5%&#x000a0;before 2000 to&#x000a0;72.2%&#x000a0;between 2005 and 2009.&#x000a0;Conversely, was not a significant increase in the rate of non-HPV oropharyngeal cancers&#x000a0;within the same period.<xref ref-type="bibr" rid="article-30251.r4">[4]</xref></p>
      </sec>
      <sec id="article-30251.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>HPV is a double-stranded DNA virus implicated in a host of carcinomas throughout the body. HPV 16 has the greatest association with oropharyngeal cancers, with other oncogenic strains including HPV 18 being less common<xref ref-type="bibr" rid="article-30251.r5">[5]</xref>. p16 is a tumor-suppressor protein that&#x000a0;is overexpressed in HPV-positive tumors and is well established as a useful surrogate marker of HPV in tonsil cancer.<xref ref-type="bibr" rid="article-30251.r6">[6]</xref></p>
        <p>The&#x000a0;fourth edition of the World Health Organization's Classification of Head and Neck Tumors&#x000a0;has made a number of changes to reflect our current understanding of the disease. Oral and oropharyngeal cancers are now separate clinical entities, due to the presence of&#x000a0;lymphoepithelial tissues within areas such as the tonsils. Most tonsil cancers are squamous cell carcinomas (SCC). However, the WHO classification now subdivides this into two distinct morphological groups; HPV positive and HPV negative. HPV positive SCCs arise from the deep lymphoid tissue of the tonsillar crypts and have a non-keratinising morphology. HPV negative SCC develops from the oropharyngeal/tonsil surface epithelium and is associated with&#x000a0;keratinizing dysplasia.<xref ref-type="bibr" rid="article-30251.r7">[7]</xref></p>
      </sec>
      <sec id="article-30251.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Tonsillar cancers can have a highly variable clinical history. Patient's may have complaints of a sore throat, unilateral otalgia, or sensation of a mass in the throat, with trismus being a concerning sign of local invasion.&#x000a0;Others may be asymptomatic and referred as an incidental finding of asymmetrical tonsils.&#x000a0;The tonsil's rich lymphatic supply means many tumors present as an occult lesion with enlarged cervical nodes, in particular within the jugulodigastric region. It is vital to ask the patient about red flag symptoms including weight loss, odynophagia, dysphagia, and persistent hoarseness. Thorough past medical history and discussion of etiological factors including smoking, increased alcohol intake and risk behaviors&#x000a0;(e.g., intravenous drug use) may help elicit an underlying cause.&#x000a0;</p>
        <p>HPV-positive tumors will typically present in younger non-smoking patients of either gender, while HPV-negative tumors will present in older male smokers with more co-morbidities, and thus have a poorer prognosis overall.</p>
        <p>Patients require a full ear, nose, and throat examination by an experienced otolaryngologist,&#x000a0;including palpation of the neck for cervical lymphadenopathy and close inspection&#x000a0;of the oropharynx.&#x000a0;Particular attention should be paid to the tonsil beds as primary cancers can be missed within the tonsil crypts. Flexible nasal endoscopy should&#x000a0;be performed in all patients for a thorough assessment of the oropharynx including inspection of the tonsils, tongue base, vallecula, and lateral pharyngeal wall for signs of local invasion.</p>
      </sec>
      <sec id="article-30251.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Imaging&#x000a0;</bold>
</p>
        <p>All cases of tonsillar cancer will need through pre-treatment cross-sectional imaging, with contrast-enhanced MRI providing the best quality&#x000a0;soft tissue delineation of the primary disease and local spread.<xref ref-type="bibr" rid="article-30251.r8">[8]</xref>&#x000a0;CT can also&#x000a0;assess the primary disease&#x000a0;although an artifact from adjacent dental treatments often limits this. CT is currently&#x000a0;the imaging modality of choice for staging all head and neck cancers and&#x000a0;should&#x000a0;be performed&#x000a0;from skull base to diaphragm to look for associated nodal and pulmonary disease.<xref ref-type="bibr" rid="article-30251.r9">[9]</xref></p>
        <p>PET-CT can also be used in tonsil cancer&#x000a0;as a means&#x000a0;to help with diagnosis&#x000a0;and staging in difficult to detect cancers<xref ref-type="bibr" rid="article-30251.r10">[10]</xref>&#x000a0;and in post-treatment surveillance.<xref ref-type="bibr" rid="article-30251.r11">[11]</xref>.&#x000a0;However, it&#x000a0;is limited by its false-positive findings, frequently showing uptake in contralateral tonsils,<xref ref-type="bibr" rid="article-30251.r12">[12]</xref>&#x000a0;tongue base and Waldeyer's ring<xref ref-type="bibr" rid="article-30251.r10">[10]</xref> without the presence of malignancy.</p>
        <p>
<bold>Endoscopy&#x000a0;</bold>
</p>
        <p>It is strongly recommended all suspected tonsillar cancers undergo an examination under anesthesia&#x000a0;and panendoscopy.<xref ref-type="bibr" rid="article-30251.r13">[13]</xref>&#x000a0;This can&#x000a0;facilitate&#x000a0;close assessment and biopsy of the disease, planning of surgical interventions, and exclusion of secondary malignancies within the upper airway and esophagus.&#x000a0;FNA biopsies have been used&#x000a0;in those who are unfit for surgery; however,&#x000a0;the reliability of HPV testing in cytology samples has been questioned.<xref ref-type="bibr" rid="article-30251.r14">[14]</xref></p>
      </sec>
      <sec id="article-30251.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p><bold>Surgical&#x000a0;Management</bold>&#x000a0;&#x000a0;</p>
        <p>Early tonsil cancer is preferably managed with single modality treatment, with transoral&#x000a0;robotic surgery (TORS) and transoral laser microsurgery (TLM) having comparable oncological outcomes.<xref ref-type="bibr" rid="article-30251.r15">[15]</xref>&#x000a0;TORs is growing in popularity and has&#x000a0;been shown to have reduced operating time, shorter hospital stay, and improved swallowing recovery compared to open techniques<xref ref-type="bibr" rid="article-30251.r16">[16]</xref>;&#x000a0;although, persistent severe dysphagia can occur post-operatively.<xref ref-type="bibr" rid="article-30251.r17">[17]</xref>&#x000a0;TLM&#x000a0;is less widely adopted and involves removal of&#x000a0;the tumor in several pieces, making&#x000a0;a histological examination of margins&#x000a0;difficult.<xref ref-type="bibr" rid="article-30251.r13">[13]</xref>&#x000a0;Regardless of the method of surgical intervention, it&#x000a0;is advised to remove both tonsils at time of surgery due to a small rate of bilateral synchronous tonsillar cancers.<xref ref-type="bibr" rid="article-30251.r18">[18]</xref></p>
        <p>In more advanced disease, TLM or TORS can still&#x000a0;be offered for early T3 tumors; however, this is often not possible for T4 malignancies. Most of these cases will instead undergo chemoradiotherapy, as a surgical intervention will usually require a mandibulotomy&#x000a0;and extensive surgical reconstruction resulting in poor post-operative functional outcomes.<xref ref-type="bibr" rid="article-30251.r13">[13]</xref></p>
        <p>Given the high rate of nodal disease in&#x000a0;both early and advanced tonsillar cancer, it is recommended&#x000a0;that most cases undergoing surgical intervention should also&#x000a0;have an elective level II to IV neck dissection.<xref ref-type="bibr" rid="article-30251.r19">[19]</xref></p>
        <p>
<bold>Oncological Management</bold>
</p>
        <p>Primary radiotherapy for early tonsillar cancer has been shown&#x000a0;to have good oncological outcomes and overall survival.&#x000a0;Unilateral radiotherapy&#x000a0;to&#x000a0;levels II to IV&#x000a0;can&#x000a0;be used&#x000a0;in non-lateralized&#x000a0;cancers with a low rate of contralateral nodal recurrence and improved rates of&#x000a0;radiation&#x000a0;toxicity.<xref ref-type="bibr" rid="article-30251.r20">[20]</xref>&#x000a0;It&#x000a0;is advised&#x000a0;to treat those with contralateral nodes with bilateral radiotherapy.<xref ref-type="bibr" rid="article-30251.r13">[13]</xref>&#x000a0;</p>
        <p>A previous&#x000a0;Cochrane&#x000a0;review&#x000a0;has established&#x000a0;chemoradiotherapy as the management of choice&#x000a0;for&#x000a0;advanced tonsil and oropharyngeal cancers.<xref ref-type="bibr" rid="article-30251.r21">[21]</xref>&#x000a0;This avoids the need for extensive surgery which carries significant long-term morbidity and often requires post-operative chemoradiotherapy.&#x000a0;Radiotherapy in addition to concurrent platinum-based cisplatin chemotherapy is the most widely used regime, with the monoclonal antibody cetuximab being used as&#x000a0;an equally effective alternative in cases&#x000a0;where cisplatin is contraindicated (renal impairment and hearing loss).<xref ref-type="bibr" rid="article-30251.r22">[22]</xref></p>
      </sec>
      <sec id="article-30251.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The histological differential diagnosis of suspected tonsillar cancer includes;&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Squamous cell carcinoma</p>
          </list-item>
          <list-item>
            <p>Lymphoma</p>
          </list-item>
          <list-item>
            <p>Small cell carcinoma (rare and very aggressive<xref ref-type="bibr" rid="article-30251.r23">[23]</xref>)</p>
          </list-item>
          <list-item>
            <p>Several case reports document&#x000a0;rare primary sites metastasizing to the tonsil including Merkel cell carcinoma<xref ref-type="bibr" rid="article-30251.r24">[24]</xref>, renal cell carcinoma,<xref ref-type="bibr" rid="article-30251.r25">[25]</xref>&#x000a0;rectal adenocarcinoma,<xref ref-type="bibr" rid="article-30251.r26">[26]</xref> and small cell lung cancer<xref ref-type="bibr" rid="article-30251.r27">[27]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30251.s10" sec-type="Staging">
        <title>Staging</title>
        <p>Tonsil malignancy is staged as oropharyngeal cancer according to the&#x000a0;AJCC TNM classification of malignant tumors. The 2016 eight edition splits oropharyngeal cancer into p16 positive and negative cancers to reflect the current&#x000a0;understanding of the influence of HPV and p16 on the prognosis and management.<xref ref-type="bibr" rid="article-30251.r28">[28]</xref>&#x000a0;This marks a dramatic change from previous editions of the manual, and can significantly alter the final staging of the malignancy.</p>
        <p>
<bold>T Classification Oropharyngeal Cancers</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>T1: Tumor 2 cm or less&#x000a0;</p>
          </list-item>
          <list-item>
            <p>T2: Tumor&#x000a0;more than 2 cm but less than 4 cm</p>
          </list-item>
          <list-item>
            <p>T3: Tumor greater than 4 cm or extension into the lingual surface of epiglottis</p>
          </list-item>
          <list-item>
            <p>p16 negative&#x000a0;tumors
<list list-type="bullet"><list-item><p>T4a: Tumor invades larynx, deep/extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible</p></list-item><list-item><p>T4b: Tumor&#x000a0;invades&#x000a0;lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, skull base; or encases carotid artery</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>p16 positive tumors&#x000a0;
<list list-type="bullet"><list-item><p>T4: Larynx, deep/extrinsic muscle of tongue, medial pterygoid, hard palate, mandible, lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, skull base; or encases carotid artery</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>N Classification p16 Negative</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>N0: No regional lymph node metastasis</p>
          </list-item>
          <list-item>
            <p>N1: Single ipsilateral node less than 3 cm&#x000a0;</p>
          </list-item>
          <list-item>
            <p>N2
<list list-type="bullet"><list-item><p>N2a: Single ipsilateral node greater than 3 cm but less than 6cm&#x000a0;</p></list-item><list-item><p>N2b: Multiple ipsilateral nodes less than 6 cm</p></list-item><list-item><p>N2c: Bilateral and contralateral nodes less than 6cm</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>N3
<list list-type="bullet"><list-item><p>N3a: Single node greater than 6 cm</p></list-item><list-item><p>N3b: Single or multiple nodes with extra-capsular spread</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>N Classification p16 Positive</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>N0: No regional lymph node metastasis</p>
          </list-item>
          <list-item>
            <p>N1: Unilateral nodes all less than 6 cm</p>
          </list-item>
          <list-item>
            <p>N2: Contralateral or bilateral nodes all less than 6 cm</p>
          </list-item>
          <list-item>
            <p>N3: Metastasis greater than 6 cm</p>
          </list-item>
        </list>
        <p>
<bold>M Classification</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>M0: No distant metastasis</p>
          </list-item>
          <list-item>
            <p>M1: Distant metastasis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30251.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis of tonsil&#x000a0;cancer is dependent on the HPV status of the tumor, with HPV positive tumors&#x000a0;showing a 5-year&#x000a0;overall survival of&#x000a0;71% compared to 46% in HPV negative disease in one study.<xref ref-type="bibr" rid="article-30251.r29">[29]</xref>&#x000a0;However, this survival benefit can be negated&#x000a0;by the presence of smoking, with mortality rates being significantly higher in HPV-positive smokers compared to non-smokers.<xref ref-type="bibr" rid="article-30251.r30">[30]</xref>&#x000a0;Other factors including&#x000a0;low volume tumors, lack of nodal disease, young age, low comorbid status, and presence of tumor&#x000a0;invading lymphocytes&#x000a0;are thought to influence prognosis in oropharyngeal tumors positively.<xref ref-type="bibr" rid="article-30251.r31">[31]</xref>&#x000a0;There are no studies directly comparing survival outcomes in tonsil cancers managed with a single modality surgical or oncological management.</p>
      </sec>
      <sec id="article-30251.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Untreated tonsillar cancer will result in&#x000a0;gradual growth and invasion of local structures. Invasion&#x000a0;of the&#x000a0;lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, skull base and encasement around the carotid&#x000a0;is suggestive of unresectable&#x000a0;T4b disease in p16 negative cancers.&#x000a0;Moreover, invasion of the skull base and vertebral tissues can interfere with emerging nerves, resulting in Horner's syndrome and palsies of the brachial plexus and phrenic nerve. Encasement of the carotid artery can cause&#x000a0;a life-threatening carotid blow-out.</p>
        <p>The management options of tonsil cancer can also carry significant complications. TORS can result in significant pain and dysphagia postoperatively, particularly in advanced disease. Radiotherapy frequently causes mucositis, xerostomia, and skin reactions, which can also have a significant impact on swallowing.<xref ref-type="bibr" rid="article-30251.r32">[32]</xref>&#x000a0;These effects can be amplified in those who undergo TORS resection with post-operative chemo-radiotherapy, who have reported significantly worse swallowing and quality of life outcomes compared to those undergoing single modality treatments.<xref ref-type="bibr" rid="article-30251.r33">[33]</xref></p>
      </sec>
      <sec id="article-30251.s13" sec-type="Consultations">
        <title>Consultations</title>
        <list list-type="bullet">
          <list-item>
            <p>Otolaryngologists</p>
          </list-item>
          <list-item>
            <p>Oncologists</p>
          </list-item>
          <list-item>
            <p>Radiologists</p>
          </list-item>
          <list-item>
            <p>Plastic/maxillofacial surgeons</p>
          </list-item>
          <list-item>
            <p>Restorative dentists</p>
          </list-item>
          <list-item>
            <p>Clinical nurse specialists</p>
          </list-item>
          <list-item>
            <p>Dieticians</p>
          </list-item>
          <list-item>
            <p>Speech and language&#x000a0;therapists</p>
          </list-item>
          <list-item>
            <p>Palliative care</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30251.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Advice on alcohol and&#x000a0;smoking cessation should&#x000a0;be offered to all patients given their etiological and prognostic influence. HPV vaccination&#x000a0;is a controversial topic within the lay media, and although numerous studies have&#x000a0;established their effectiveness&#x000a0;in the prevention of&#x000a0;gynecological malignancies, there is&#x000a0;little evidence supporting their use in tonsillar cancers.&#x000a0;Moreover, the&#x000a0;lack of a&#x000a0;pre-malignant stage (as seen in cervical CIS) and&#x000a0;differences in&#x000a0;HPV&#x000a0;epidemiology between&#x000a0;cancers&#x000a0;could present barriers to its effectiveness.<xref ref-type="bibr" rid="article-30251.r34">[34]</xref>&#x000a0;Nevertheless, vaccination of females and males in several countries including the United Kindom, United States, Canada,&#x000a0;and Australia&#x000a0;is hoped to reduce the rates of oropharyngeal cancers long term.</p>
      </sec>
      <sec id="article-30251.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Management of tonsil cancer requires an interprofessional approach. The initial investigation occurs within the otolaryngology outpatient setting, with the involvement of&#x000a0;radiology and pathology departments proving vital for definitive diagnosis and clinical staging. Otolaryngologists and oncologists will ultimately manage the disease with a specialist interest in&#x000a0;head and neck cancer; however, support is required from speech and language therapists, nurse specialists, and dietician teams to&#x000a0;manage the resultant swallowing, emotional, and nutritional issues. For those undergoing radiotherapy, a review by restorative dentistry is necessary&#x000a0;to avoid debilitating osteoradionecrosis.</p>
      </sec>
      <sec id="article-30251.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30251&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30251">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/tonsil-cancer/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30251">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30251/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30251">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-30251.s17">
        <fig id="article-30251.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Tonsillar mass Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="tonsillar__mass" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-30251.s18">
        <title>References</title>
        <ref id="article-30251.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>N&#x000e4;sman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Attner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hammarstedt</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Eriksson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Giraud</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ahrlund-Richter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marklund</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Romanitan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lindquist</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ramqvist</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lindholm</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Spar&#x000e9;n</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Dahlstrand</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Munck-Wikland</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dalianis</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?</article-title>
            <source>Int J Cancer</source>
            <year>2009</year>
            <month>Jul</month>
            <day>15</day>
            <volume>125</volume>
            <issue>2</issue>
            <fpage>362</fpage>
            <page-range>362-6</page-range>
            <pub-id pub-id-type="pmid">19330833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mirghani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sturgis</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Aup&#x000e9;rin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Monsonego</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Blanchard</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Is there an increased risk of cancer among spouses of patients with an HPV-related cancer: A systematic review.</article-title>
            <source>Oral Oncol</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>67</volume>
            <fpage>138</fpage>
            <page-range>138-145</page-range>
            <pub-id pub-id-type="pmid">28351568</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weatherspoon</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Chattopadhyay</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boroumand</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000-2010.</article-title>
            <source>Cancer Epidemiol</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>39</volume>
            <issue>4</issue>
            <fpage>497</fpage>
            <page-range>497-504</page-range>
            <pub-id pub-id-type="pmid">25976107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehanna</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Beech</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nicholson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>El-Hariry</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>McConkey</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Paleri</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region.</article-title>
            <source>Head Neck</source>
            <year>2013</year>
            <month>May</month>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>747</fpage>
            <page-range>747-55</page-range>
            <pub-id pub-id-type="pmid">22267298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kreimer</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Clifford</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Boyle</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Franceschi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>467</fpage>
            <page-range>467-75</page-range>
            <pub-id pub-id-type="pmid">15734974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hassani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Castillo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ohori</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Higashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kurono</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Akiba</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Koriyama</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Molecular Pathogenesis of Human Papillomavirus Type 16 in Tonsillar Squamous Cell Carcinoma.</article-title>
            <source>Anticancer Res</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>35</volume>
            <issue>12</issue>
            <fpage>6633</fpage>
            <page-range>6633-8</page-range>
            <pub-id pub-id-type="pmid">26637879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Westra</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Oropharynx.</article-title>
            <source>Head Neck Pathol</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-47</page-range>
            <pub-id pub-id-type="pmid">28247229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewis-Jones</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Colley</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gibson</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Imaging in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.</article-title>
            <source>J Laryngol Otol</source>
            <year>2016</year>
            <month>May</month>
            <volume>130</volume>
            <issue>S2</issue>
            <fpage>S28</fpage>
            <page-range>S28-S31</page-range>
            <pub-id pub-id-type="pmid">27841111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loh</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Gilbert</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Gullane</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Irish</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>A rational approach to pulmonary screening in newly diagnosed head and neck cancer.</article-title>
            <source>Head Neck</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>27</volume>
            <issue>11</issue>
            <fpage>990</fpage>
            <page-range>990-4</page-range>
            <pub-id pub-id-type="pmid">16136584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wong</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Sonoda</surname>
                <given-names>LI</given-names>
              </name>
              <name>
                <surname>Gharpurhy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gollub</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wellsted</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Goodchild</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lemon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Farrell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Saunders</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of occult primary head and neck cancers--an audit and review of published studies.</article-title>
            <source>Clin Oncol (R Coll Radiol)</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>24</volume>
            <issue>3</issue>
            <fpage>190</fpage>
            <page-range>190-5</page-range>
            <pub-id pub-id-type="pmid">22183080</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehanna</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>McConkey</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Nutting</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hartley</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hulme</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Zeidler</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sanghera</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fresco</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.</article-title>
            <source>Health Technol Assess</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>17</issue>
            <fpage>1</fpage>
            <page-range>1-122</page-range>
            <pub-id pub-id-type="pmid">28409743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirshoren</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Olayos</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Callahan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>PET/CT findings within the contralateral tonsil following unilateral tonsillectomy.</article-title>
            <source>Laryngoscope</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>126</volume>
            <issue>11</issue>
            <fpage>2480</fpage>
            <page-range>2480-2483</page-range>
            <pub-id pub-id-type="pmid">27114188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehanna</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Beasley</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chatterjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dilkes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Homer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>O'Hara</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sloan</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines.</article-title>
            <source>J Laryngol Otol</source>
            <year>2016</year>
            <month>May</month>
            <volume>130</volume>
            <issue>S2</issue>
            <fpage>S90</fpage>
            <page-range>S90-S96</page-range>
            <pub-id pub-id-type="pmid">27841123</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takes</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Kaanders</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>van Herpen</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Merkx</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Slootweg</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Melchers</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Human papillomavirus detection in fine needle aspiration cytology of lymph node metastasis of head and neck squamous cell cancer.</article-title>
            <source>J Clin Virol</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>85</volume>
            <fpage>22</fpage>
            <page-range>22-26</page-range>
            <pub-id pub-id-type="pmid">27816020</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moore</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Hinni</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Critical review: transoral laser microsurgery and robotic-assisted surgery for oropharynx cancer including human papillomavirus-related cancer.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2013</year>
            <month>Apr</month>
            <day>01</day>
            <volume>85</volume>
            <issue>5</issue>
            <fpage>1163</fpage>
            <page-range>1163-7</page-range>
            <pub-id pub-id-type="pmid">23182390</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Byeon</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Comparison of oncologic and functional outcomes after transoral robotic lateral oropharyngectomy versus conventional surgery for T1 to T3 tonsillar cancer.</article-title>
            <source>Head Neck</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>36</volume>
            <issue>8</issue>
            <fpage>1138</fpage>
            <page-range>1138-45</page-range>
            <pub-id pub-id-type="pmid">23836492</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Hinni</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Pollei</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Hayden</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Severe prolonged dysphagia following transoral resection of bilateral synchronous tonsillar carcinoma.</article-title>
            <source>Eur Arch Otorhinolaryngol</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>272</volume>
            <issue>11</issue>
            <fpage>3585</fpage>
            <page-range>3585-91</page-range>
            <pub-id pub-id-type="pmid">25663269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rokkjaer</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Klug</surname>
                <given-names>TE</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of synchronous bilateral tonsil squamous cell carcinoma: A retrospective study.</article-title>
            <source>Clin Otolaryngol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-6</page-range>
            <pub-id pub-id-type="pmid">28891195</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gr&#x000e9;goire</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Budach</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Grau</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hamoir</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Langendijk</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Le</surname>
                <given-names>QT</given-names>
              </name>
              <name>
                <surname>Maingon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nutting</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>O'Sullivan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Porceddu</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Lengele</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines.</article-title>
            <source>Radiother Oncol</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>110</volume>
            <issue>1</issue>
            <fpage>172</fpage>
            <page-range>172-81</page-range>
            <pub-id pub-id-type="pmid">24183870</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Charbonneau</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>G&#x000e9;linas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>del Vecchio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Guertin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Larochelle</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tabet</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Souli&#x000e8;res</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Charpentier</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nguyen-T&#x000e2;n</surname>
                <given-names>PF</given-names>
              </name>
            </person-group>
            <article-title>Primary radiotherapy for tonsillar carcinoma: a good alternative to a surgical approach.</article-title>
            <source>J Otolaryngol</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>227</fpage>
            <page-range>227-34</page-range>
            <pub-id pub-id-type="pmid">17176797</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Glenny</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Weldon</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Furness</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Worthington</surname>
                <given-names>HV</given-names>
              </name>
              <name>
                <surname>Wakeford</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2015</year>
            <month>Dec</month>
            <day>01</day>
            <volume>2015</volume>
            <issue>12</issue>
            <fpage>CD010341</fpage>
            <pub-id pub-id-type="pmid">26625332</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Onita</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lester D R</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Iman A</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jergin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shawn</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Comparison of high-dose Cisplatin-based chemoradiotherapy and Cetuximab-based bioradiotherapy for p16-positive oropharyngeal squamous cell carcinoma in the context of revised HPV-based staging.</article-title>
            <source>Rep Pract Oncol Radiother</source>
            <year>2018</year>
            <season>Sep-Oct</season>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>451</fpage>
            <page-range>451-457</page-range>
            <pub-id pub-id-type="pmid">30210266</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sehdev</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Primary small cell carcinoma of the tonsil: a case report and review of the literature.</article-title>
            <source>Case Rep Oncol</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>537</fpage>
            <page-range>537-41</page-range>
            <pub-id pub-id-type="pmid">23139668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vasileiadis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sofopoulos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Arnogiannaki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Georgopoulos</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A Merkel-cell carcinoma metastatic to the tonsil: a case report and review of the literature.</article-title>
            <source>J Oral Maxillofac Surg</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>71</volume>
            <issue>10</issue>
            <fpage>1812.e1</fpage>
            <page-range>1812.e1-6</page-range>
            <pub-id pub-id-type="pmid">23911145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Massaccesi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morganti</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Serafini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Di Lallo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Deodato</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Picardi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Scambia</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Late tonsil metastases from renal cell cancer: a case report.</article-title>
            <source>Tumori</source>
            <year>2009</year>
            <season>Jul-Aug</season>
            <volume>95</volume>
            <issue>4</issue>
            <fpage>521</fpage>
            <page-range>521-4</page-range>
            <pub-id pub-id-type="pmid">19856668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Palatine tonsillar metastasis of rectal adenocarcinoma: a case report and literature review.</article-title>
            <source>World J Surg Oncol</source>
            <year>2013</year>
            <month>May</month>
            <day>25</day>
            <volume>11</volume>
            <fpage>114</fpage>
            <pub-id pub-id-type="pmid">23705669</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Unsal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kutlar</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sullu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yurtlu</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Tonsillar metastasis of small cell lung carcinoma.</article-title>
            <source>Clin Respir J</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>10</volume>
            <issue>6</issue>
            <fpage>681</fpage>
            <page-range>681-683</page-range>
            <pub-id pub-id-type="pmid">25620524</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lydiatt</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>O'Sullivan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Brandwein</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Ridge</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Migliacci</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Loomis</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual.</article-title>
            <source>CA Cancer J Clin</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>122</fpage>
            <page-range>122-137</page-range>
            <pub-id pub-id-type="pmid">28128848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Charfi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jouffroy</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>de Cremoux</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Le Peltier</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Thioux</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fr&#x000e9;neaux</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Point</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Girod</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sastre-Garau</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome.</article-title>
            <source>Cancer Lett</source>
            <year>2008</year>
            <month>Feb</month>
            <day>18</day>
            <volume>260</volume>
            <issue>1-2</issue>
            <fpage>72</fpage>
            <page-range>72-8</page-range>
            <pub-id pub-id-type="pmid">18060686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gillison</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Jordan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Westra</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Trotti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Ang</surname>
                <given-names>KK</given-names>
              </name>
            </person-group>
            <article-title>Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer.</article-title>
            <source>J Clin Oncol</source>
            <year>2012</year>
            <month>Jun</month>
            <day>10</day>
            <volume>30</volume>
            <issue>17</issue>
            <fpage>2102</fpage>
            <page-range>2102-11</page-range>
            <pub-id pub-id-type="pmid">22565003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ward</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Thirdborough</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Mellows</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Riley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Suchak</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hampton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Randall</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Jogai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Primrose</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Piper</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ottensmeier</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>EV</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer.</article-title>
            <source>Br J Cancer</source>
            <year>2014</year>
            <month>Jan</month>
            <day>21</day>
            <volume>110</volume>
            <issue>2</issue>
            <fpage>489</fpage>
            <page-range>489-500</page-range>
            <pub-id pub-id-type="pmid">24169344</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rusthoven</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Raben</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ballonoff</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kane</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Effect of radiation techniques in treatment of oropharynx cancer.</article-title>
            <source>Laryngoscope</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>118</volume>
            <issue>4</issue>
            <fpage>635</fpage>
            <page-range>635-9</page-range>
            <pub-id pub-id-type="pmid">18176348</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Achim</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bolognone</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Palmer</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Graville</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Light</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Clayburgh</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Long-term Functional and Quality-of-Life Outcomes After Transoral Robotic Surgery in Patients With Oropharyngeal Cancer.</article-title>
            <source>JAMA Otolaryngol Head Neck Surg</source>
            <year>2018</year>
            <month>Jan</month>
            <day>01</day>
            <volume>144</volume>
            <issue>1</issue>
            <fpage>18</fpage>
            <page-range>18-27</page-range>
            <pub-id pub-id-type="pmid">29075740</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30251.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Eisele</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Fakhry</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.</article-title>
            <source>Cancer</source>
            <year>2016</year>
            <month>Aug</month>
            <day>01</day>
            <volume>122</volume>
            <issue>15</issue>
            <fpage>2313</fpage>
            <page-range>2313-23</page-range>
            <pub-id pub-id-type="pmid">27152637</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
